JERSEY CITY, N.J., Sept. 18 /PRNewswire/ -- Lux Biosciences, Inc., a privately held biotechnology company specialized in the field of ophthalmic diseases, today announced that it has established Lux Biosciences GmbH in Frankfurt, Germany as a wholly owned subsidiary with the mission to create the infrastructure for the company’s European activities.
